ZA908852B - Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones - Google Patents

Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones

Info

Publication number
ZA908852B
ZA908852B ZA908852A ZA908852A ZA908852B ZA 908852 B ZA908852 B ZA 908852B ZA 908852 A ZA908852 A ZA 908852A ZA 908852 A ZA908852 A ZA 908852A ZA 908852 B ZA908852 B ZA 908852B
Authority
ZA
South Africa
Prior art keywords
pyridyloxazole
ones
treatment
drug resistant
resistant tumors
Prior art date
Application number
ZA908852A
Other languages
English (en)
Inventor
Sai Prasad Sunkara
Prasad Sunkara Sai
Winton Dennis Jones
Dennis Jones Winton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA908852B publication Critical patent/ZA908852B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA908852A 1989-11-13 1990-11-05 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones ZA908852B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43626389A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
ZA908852B true ZA908852B (en) 1991-09-25

Family

ID=23731765

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908852A ZA908852B (en) 1989-11-13 1990-11-05 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones

Country Status (6)

Country Link
EP (1) EP0428104A3 (xx)
JP (1) JP2947919B2 (xx)
KR (1) KR0168646B1 (xx)
AU (1) AU641443B2 (xx)
IE (1) IE904076A1 (xx)
ZA (1) ZA908852B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE155686T1 (de) * 1991-05-14 1997-08-15 Merrell Pharma Inc Hemmung von metastasen bei krebspatienten mit pyridyloxazol-2-onen
WO1993010778A1 (en) * 1991-12-02 1993-06-10 Merrell Dow Pharmaceuticals Inc. Inhibition of angiogenesis with pyridinyloxazole-2-ones
KR950700061A (ko) * 1992-02-06 1995-01-16 스티븐 엘. 네스비트 테트라아릴에틸렌에 의한 다중 약물 내성의 역전(reversal of multi -drug resistance by tetraarylethylenes)
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen

Also Published As

Publication number Publication date
KR910009262A (ko) 1991-06-28
IE904076A1 (en) 1991-05-22
KR0168646B1 (ko) 1999-01-15
AU6592490A (en) 1991-05-16
JPH03170427A (ja) 1991-07-24
AU641443B2 (en) 1993-09-23
JP2947919B2 (ja) 1999-09-13
EP0428104A3 (en) 1991-12-11
EP0428104A2 (en) 1991-05-22

Similar Documents

Publication Publication Date Title
GB8921123D0 (en) Treatment of ards
GB8921326D0 (en) Novel treatment
GB8918297D0 (en) Novel treatment
GB8810748D0 (en) Novel treatment
ZA908852B (en) Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
GB8828679D0 (en) Novel treatment
GB8908539D0 (en) Treatment of cancer
GB8816505D0 (en) Novel treatment
GB2236539B (en) Treatment of spirits
GB8903284D0 (en) Treatment of materials
IE891751L (en) Treatment of arthritis
GB8914965D0 (en) Novel treatment ii
GB8914964D0 (en) Novel treatment i
GB8925965D0 (en) Novel treatment
GB8921028D0 (en) Novel treatment
GB8921029D0 (en) Novel treatment
GB8921030D0 (en) Novel treatment
GB8914857D0 (en) Novel treatment
GB8921026D0 (en) Novel treatment
GB8928163D0 (en) Novel treatment
GB8911711D0 (en) Novel treatment
GB8910090D0 (en) Novel treatment
GB8907781D0 (en) Novel treatment
GB8907760D0 (en) Novel treatment
GB8921027D0 (en) Novel treatment